Off-Label Treatments for Papulosquamous Diseases: Insights from Dr. Adam Friedman
At the 2025 ODAC Dermatology Conference, we had the privilege of hearing from Dr. Adam Friedman, a renowned expert in dermatology and the chair of the department of dermatology at the George Washington, as he shared his expert insights into the evolving landscape of off-label treatments for challenging dermatologic conditions. Dr. Friedman addressed the complexities of managing conditions such as …
At the 2025 ODAC Dermatology Conference, we had the privilege of hearing from Dr. Adam Friedman, a renowned expert in dermatology and the chair of the department of dermatology at the George Washington, as he shared his expert insights into the evolving landscape of off-label treatments for challenging dermatologic conditions. Dr. Friedman addressed the complexities of managing conditions such as … Continue reading "Off-Label Treatments for Papulosquamous Diseases: Insights from Dr. Adam Friedman"
“Try to do something” is Dr. Candrice R. Heath’s motto for clinicians when treating pediatric vitiligo. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Heath, associate professor of dermatology at Howard University. Watch as Dr. Heath provides insight as a pediatric dermatologist into treating vitiligo in children. Learn why understanding the parent and patient … 
This month’s Patient Buzz contains several articles that address basic skin and hair care questions. Time addressed whether people should use soap or cleanser when bathing. Dermatologists Drs. Erin Chen, Anthony Rossi, Rachel Nazarian, and Shilpi Khetarpal outlined the damage that soap can do to the skin, and the benefits of using cleansers in maintaining the skin barrier. The dermatologists als … 
Colchicine, a microtubule polymerization inhibitor, was first described for use in treating joint pain and swelling in ancient Egypt and has since become a mainstay in the medical management of gout. Beyond its indicated uses, it has numerous off-label dermatologic applications, particularly for neutrophilic and autoimmune conditions. As a potent anti-inflammatory, colchicine requires careful lab … 
The past year has been an extraordinary time in drug approvals in medical dermatology, especially the approval of treatments that impact patients with skin of color, according to Dr. Andrew F. Alexis, co-chair of Skin of Color Update. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Alexis, who is also vice-chair for diversity and inclusion for the Weill Cornell Medica … 